Status:
COMPLETED
RaFIST: A Radiomics-Based Tool for Intratumoral Fibrosis Stratification in Non-Small Cell Lung Cancer
Lead Sponsor:
Jinling Hospital, China
Conditions:
Lung Cancer - Non Small Cell
Eligibility:
All Genders
18+ years
Brief Summary
Patients with suspected Lung cancer who underwent contrast-enhanced CT and pathological examinations at Center 1 between January 2011 and January 2020 and Center 2 between September 2017 and Januray 2...
Eligibility Criteria
Inclusion
- Solid pulmonary nodule detected on CECT within 3 weeks pre-resection
- No history of previous treatment such as chemotherapy, or radiotherapy
Exclusion
- Unavailable pathological sections
- Missing CT images or hard-to-annotate CT images
- Undergone anticancer therapy before CT
- Loss to follow-up
- Concurrent other malignant tumors
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2025
Estimated Enrollment :
508 Patients enrolled
Trial Details
Trial ID
NCT06908005
Start Date
April 1 2024
End Date
March 1 2025
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinling Hospital
Nanjing, Jiangsu, China, 210000